36881-14-8

Basic information

• Product Name: Propanoic acid, 2,2-dimethyl-3-(phenylmethoxy)-
• CAS NO: 36881-14-8
• Molecular Formula: C12H16O3
• Molecular Weight: 208.257
• Mol File: 36881-14-8.mol
• Article Data: 14

Chemical Properties

• CAS DataBase Reference: Propanoic acid, 2,2-dimethyl-3-(phenylmethoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: Propanoic acid, 2,2-dimethyl-3-(phenylmethoxy)-(36881-14-8)
• EPA Substance Registry System: Propanoic acid, 2,2-dimethyl-3-(phenylmethoxy)-(36881-14-8)

Safety Data

• Hazardous Substances Data: 36881-14-8(Hazardous Substances Data)

Upstream product

• 38216-93-2 3-benzyloxypivalic aldehyde 
• 17690-16-3 benzyl bromomethyl ether 
• 16423-62-4 dilithiated 2-methylpropionic acid 
• 776-88-5 5,5-dimethyl-2-phenyl-[1,3]dioxane 
• 100-39-0 benzyl bromide 
• 66582-32-9 3-(benzyloxy)-2,2-dimethylpropan-1-ol 
• 132259-96-2 2,2-dimethyl-3-(benzyloxy)propionitrile 
• 14002-80-3 Methyl 2,2-dimethyl-3-hydroxypropionate 
• 96556-40-0 methyl-3-(benzyloxy)-2.2-dimethylpropionate 
• 141942-91-8 benzyl 3-(benzyloxy)-2,2-dimethylpropanoate 
• 1955-45-9 pivalolactone 
• 100-51-6 benzyl alcohol 

Downstream Products

• 186387-84-8 3-benzyloxy-2,2-dimethyl-1-{4-[2-(2,2,2-trifluoroethoxy)phenyl]piperazin-1-yl}-1-propanone 

Relevant articles and documents

KMnO4 REVISITED: OXIDATION OF ALDEHYDES TO CARBOXYLIC ACIDS IN THE tert-BUTYL ALCOHOL - AQUEOUS NaH2PO4 SYSTEM

Aldehydic compounds with one or more protected hydroxyl groups are effectively oxidized with KMnO4 to the corresponding carboxylic acids using a mixture of t-BuOH and aqueous NaH2PO4 as a reaction medium.

CGRP RECEPTOR ANTAGONISTS WITH TERTIARY AMIDE, SULFONAMIDE, CARBAMATE AND UREA END GROUPS

Compounds of formula I: (I) (wherein variables A, m, n, J, Re, Rf, R4, Ea, Eb, Ec, RPG and Y are as described herein) which are antagonists of CGRP receptors and which are useful

BICYCLO HETEROCYCLIC COMPOUND HAVING ANTIFUNGAL ACTION

It is intended to provide a 1,6-β-glucan synthase inhibitor which strongly inhibits proliferation and has a high safety. It is intended to provide a compound which can specifically or selectively expressing an antifungal action on a broad spectrum based on the action mechanism of inhibiting the synthesis of 1,6-β-glucan. Further, it is intended to provide a drug, in particular, an antifungal agent containing the above compound, its salt or a hydrate thereof. More specifically speaking, a compound represented by the following general formula (I), its salt or a hydrate thereof; and a drug or an antifungal agent containing the above compound, its salt or a hydrate thereof.